Clinical trial

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

NCT07609225

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-10-01

PhaseEARLY_PHASE1

Study timeline

Study start (estimated)2026-10-01Date precision: month

Registry last updated2026-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancerunresolved

Interventions

3'-Deoxy-3'-[18F]-fluorothymidineDRUG

Chemical-shift-encoded MRIDEVICE

Sponsors & collaborators

University of Wisconsin, Madisonlead sponsor

GE Healthcarecollaborator

Mapped research locations

MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07609225 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.